StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.22 on Thursday. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.21. The firm has a fifty day moving average price of $0.21 and a 200-day moving average price of $0.28. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24.
China Pharma (NYSE:CPHI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.09) earnings per share (EPS) for the quarter. The business had revenue of $0.93 million for the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- What is a Stock Market Index and How Do You Use Them?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- Do ETFs Pay Dividends? What You Need to Know
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
